CN209713828U - Two-chamber venous transfusion port - Google Patents
Two-chamber venous transfusion port Download PDFInfo
- Publication number
- CN209713828U CN209713828U CN201820895290.4U CN201820895290U CN209713828U CN 209713828 U CN209713828 U CN 209713828U CN 201820895290 U CN201820895290 U CN 201820895290U CN 209713828 U CN209713828 U CN 209713828U
- Authority
- CN
- China
- Prior art keywords
- port
- transfusion
- chamber
- port body
- catheter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000741 silica gel Substances 0.000 claims abstract description 17
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 17
- 229960001866 silicon dioxide Drugs 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 238000000465 moulding Methods 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 17
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 108010025899 gelatin film Proteins 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 8
- 238000002513 implantation Methods 0.000 abstract description 7
- 208000003322 Coinfection Diseases 0.000 abstract description 4
- 230000001732 thrombotic effect Effects 0.000 abstract description 3
- 239000003242 anti bacterial agent Substances 0.000 description 8
- 239000003146 anticoagulant agent Substances 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000003462 vein Anatomy 0.000 description 7
- 229940127219 anticoagulant drug Drugs 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000032984 Intraoperative Complications Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A kind of two-chamber venous transfusion port, the transfusion port includes transfusion catheter and by the molding columned port body of medical silica-gel, port body has cavity, the both ends of port body are hemispherical, the cavity is provided with diaphragm and separates the cavity into two chambers, the diaphragm has the micropore that penetrates through for liquid, transfusion catheter be connected to the port body one end and one of chamber.Convenient for operation implantation, operative incision is small at the two-chamber venous transfusion port, convenient for puncturing transfusion operation, and the risk of thrombotic risk and secondary infection can be effectively reduced.
Description
Technical field
The utility model relates to for venous transfusion device and intravenous transfusion methods more particularly to one kind be imbedded at patient
The subcutaneous two-chamber venous transfusion port for being used for venous transfusion.
Background technique
Referring to Fig.1, venous transfusion port is the device for being imbedded at patient and being subcutaneously used for venous transfusion comprising port body and connection
The transfusion catheter of body at port passes through its transfusion catheter and central vein (subclavian vein, neck in application, being imbedded at subcutaneously
Vein etc.) connection.When venous transfusion, venous transfusion pin puncture enters port body, and it is logical to set up infusion by port body and transfusion catheter
Road.The input of its intravenous chemotherapy drug, nutrient liquid for being widely used in malignant tumor patient, it is long-term to be also used for non-tumour patient
The case where needing venous transfusion.
The port body at traditional venous transfusion port be the bottom case being made by polythene material and as puncture face silica gel face-piece it is close
Envelope combination is constituted, and configuration design is flat circle, triangle or polygon.Such configuration design causes puncture area small, behaviour
It makes comparisons difficulty, is embedded to subcutaneous operative incision and needs 3cm or more, and port body cannot reverse needs level and implant.For
This, inventor devises a kind of full-implantation type venous transfusion port, reference can be made to the China that notification number is CN206007700U is practical new
Type patent, the full-implantation type venous transfusion port include columned port body and transfusion catheter, and port body has cavity, the both ends of port body
Hemispherical, one end has the interconnecting piece of taper, and interconnecting piece has through-hole, through-hole and cavity connection, and interconnecting piece is inserted into connection
In transfusion catheter.Since port body is cylindric medical silica-gel material, transfusion catheter is made of silica gel or polythene material, entire port
Body can be used as the entry point that puncture needle enters body cavity, greatly improve one-time successful puncture rate when transfusion operation.It is cylindric to set
Meter also makes transfusion port overall volume become smaller, notch very little when being implanted into human body, and does not need to put as flat port body
Positive position makes it easier in implantation human body；It is connect by interconnecting piece with transfusion catheter, so that port body is easier and transfusion catheter
Connection.
In further research and practice, inventor is it has furthermore been found that there is also following skills at existing venous transfusion port
Art defect: 1, transfusion port is chronically implanted in vivo, and the transfusion catheter of port intracoelomic cavity and implantation is communicated with vein, is had thrombosed
Risk brings very big inconvenience to patient so regular heparin saline is needed to rinse access.2, transfusion port repeatedly punctures that there are secondary
The risk of infection, forms septicemia when serious, need to take out transfusion port.
Utility model content
The purpose of the utility model is to provide a kind of two-chamber venous transfusion port, which is not only convenient for performing the operation
Implantation, surgical injury is small, convenient for puncturing transfusion operation, and the risk for generating thrombotic risk and secondary infection can be effectively reduced.
In order to achieve the above object, the technical solution adopted in the utility model is as follows:
A kind of two-chamber venous transfusion port comprising transfusion catheter and by the molding columned port body of medical silica-gel, it is described
Port body has cavity, and the both ends of the port body are hemispherical, in which: the cavity is provided with diaphragm, and the diaphragm is by the chamber
Body is divided into two chambers, and the diaphragm has the micropore penetrated through for liquid, and the transfusion catheter is connected to the port body
One end and one of chamber.
Preferably, the diaphragm be pellosil, the pellosil with a thickness of 1.0-1.5mm.
Preferably, the outer surface of the port body corresponds to and is provided with identification rings at the diaphragm.
Preferably, the identification rings are becket, outwardly protrusion of the identification rings from port body.
Preferably, the transfusion catheter and the port body are provided with the connector of tubulose, connector tool in connecting pin respectively
There are helicitic texture or buckle structure, the transfusion catheter and the port body are detachably connected by the connector.
Preferably, the transfusion catheter is that medical silica-gel material transfusion catheter or polythene material transfusion catheter, infusion are led
The outer diameter of pipe is 4-7F, length 130-160mm, and the internal diameter of the port body is 7-9mm, length 35-40mm, wall thickness 2-
3mm, the length for the chamber being connected to transfusion catheter are 25-30mm.
Compared with prior art, the utility model at least has the advantages that
Since port body uses the molding columned port body of medical silica-gel material, significantly increases puncture needle and enter body cavity
Entry point greatly improves one-time successful puncture rate when transfusion operation.Cylindrical design also makes transfusion port overall volume become smaller, and plants
Notch very little when entering in human body, and do not need to put on right position as flat port body, it makes it easier in implantation human body.
Since cavity is divided into two chambers by the diaphragm with micropore, close to rear end chamber storage anti-coagulants or
Antibacterial agent, anti-coagulants or antibacterial agent can slow release enter the chamber of front end and transfusion catheter and then enter vein and port body
Around tissue, can prevent thrombosis and prevent secondary infection, so as to be effectively reduced generate thrombotic risk and after
Send out the risk of infection.
Detailed description of the invention
Fig. 1 is the usage state diagram at traditional venous transfusion port；
Fig. 2 is the structural schematic diagram at exemplary embodiments venous transfusion port；
Fig. 3 is the state diagram after transfusion catheter and the separation of port body；
Fig. 4 is the partial sectional view of port body.
Specific embodiment
The utility model is described further with reference to the accompanying drawings and examples.
Referring to Figure 2 to Figure 4, exemplary embodiments two-chamber venous transfusion port includes transfusion catheter 10 and port body 20.
Transfusion catheter 10 is used to import the liquid in port body 20 in vein.The preferred medical silica-gel material of transfusion catheter 10 is defeated
Fluid catheter or polythene material transfusion catheter, the outer diameter of transfusion catheter 10 preferably 4 to 7F, the preferred 130-160mm of length.
Port body 20 is made of medical silica-gel, and cylindrical, the both ends of port body 20 are hemispherical.Medical silica-gel material is fair
Perhaps it is implanted into the high molecular material of human body, there is different consistency and elasticities, different shapes can be made by mold.It has good
Good elastical retraction effect, being voluntarily closed using its puncture needle track after not damaged puncture pin puncture not will cause fluid seepage.Together
When, another physical characteristic of silica gel material is to can be used as the carrier of liquid drug sustained release with micropore.
Port body 20 has cavity 21, and cavity 21 is provided with diaphragm 22, and the cavity 21 is divided into two chambers by diaphragm 22
23,24, the diaphragm 22 has the micropore penetrated through for liquid.The transfusion catheter 10 is connected to one end of the port body 20
It is connected to one of chamber 23.The preferred pellosil of diaphragm 22 realizes penetrating through for medical fluid using the micropore of silica gel itself,
The preferred 1.0-1.5mm of the thickness of the pellosil.
Body 20 size in port is preferably as follows: internal diameter 7-9mm, length 35-40mm, wall thickness 2-3mm, with transfusion catheter 10
The length of the chamber 23 of connection is 25-30mm.
The outer surface of port body 20 corresponds to and is provided with identification rings 25 at the diaphragm 22, with when port body 20 is implanted subcutaneous,
It still can recognize the boundary of two chambers 23,24.The preferred becket of identification rings 25, and identification rings are from the outwardly convex of port body 20
Out, the boundary of two chambers 23,24 can be not only identified by external touch manner, and can identify two by fluoroscopy techniques
The boundary of a chamber 23,24.
Transfusion catheter 10 is provided with the first connector 11 of tubulose in connecting pin, and accordingly, port body 20 is arranged in connecting pin
There is the second connector 26 of tubulose, connector has helicitic texture, and transfusion catheter 10 and port body 20 pass through connector removably
Connection.As another embodiment, buckle structure can also be set in connector, by buckle structure by transfusion catheter 10 and port
Body 20 is detachably connected.Connector preferably uses polyurethane material to suppress by die casting, viscous by ultrasonic emulsification
Even port body 20, transfusion catheter 10 are connected thereto part respectively and are linked together by technology.
One embodiment intravenous transfusion methods include:
Above-mentioned two-chamber venous transfusion port is implanted into human body.It specifically can be by way of one-step method puncture or seal wire exchange process
Two ways enters in central vein, and television perspective determines transfusion catheter head end in the position of superior vena cava, and position suitable then will
Transfusion catheter 10 and port body 20 connect.
When infusion, intravenous injection is needled into the chamber 23 being connected to transfusion catheter 10, liquid is defeated through transfusion catheter 10
Enter vein.
It is injected to the chamber 24 for not being connected to transfusion catheter 10 with 21G syringe needle in vitro or after implanting anticoagulant
Agent and/or antibacterial agent, they can be stored in for a long time in this inner cavity chamber, enter through 22 slow release of diaphragm and connect with transfusion catheter
Logical chamber 23 and transfusion catheter 10 is slowly discharged to outside the tissue around transfusion port through cavity wall simultaneously, to prevent thrombosis
And prevent secondary infection.Injection anti-coagulants or antibacterial agent can be determined according to the concrete condition of patient's therapic opportunity, such as changed
Often the stage to be used considers the more just injection antibacterial agent prevention infection of the factor of infection during treatment, if after treatment end
Anti-coagulants is injected or anti-coagulants, antibacterial agent use in turn to keep the unobstructed just extraction antibacterial agent of transfusion port, that is, is replaced
Anti-coagulants and antibacterial agent are stored to the chamber 24 for not being connected to transfusion catheter 10.
Effective inner cavity (i.e. chamber 23) length that transfusion port port body 20 is used to be infused, can be using common up to 25mm or more
Intravenous infusion needle or not damaged puncture pin puncture have breakthrough to feel and be extracted into after blood and show that needle point enters infusion inner cavity, open
Logical infusion adjusting knob, if liquid smoothly enters, transfusion port surrounding skin has no oedema caused by leakage, just illustrates transfusion port
Infusion channel is successfully established.
Using medical silica-gel as transfusion port port body material, and transfusion port port body is designed as cylindrical structure, main base
Body surface is embedded in convenient for the new theory of the artificial blood vessel punctured, by transfusion port vascularization, convenient for doctor in transfusion port is become one
Shield personnel operate and avoid being reduced venipuncture difficulty using transfusion port puncturing needle special and being reduced consumptive material expense as far as possible.Silica gel simultaneously
Material also plays medicament slow release.
Above-mentioned two-chamber venous transfusion port can be applied to important channel and the portion that Patients Receiving Chemotherapy implements intravenous chemotherapy
The patient for dividing malnourished patient, PeV medication channel to be difficult to set up is to guarantee that drug and nutriment matter can smoothly enter into body
Interior important method.
The utility model is described in detail above by specific embodiment, these detailed description are only limited to
The content of the utility model is helped skilled in the art to understand, the limit to scope of protection of the utility model can not be interpreted as
System.Those skilled in the art should all wrap various retouchings, the equivalent transformation etc. that above scheme carries out under the utility model design
Containing within the protection scope of the present utility model.
Claims (6)
1. a kind of two-chamber venous transfusion port, including transfusion catheter and by the molding columned port body of medical silica-gel, the port body
With cavity, the both ends of the port body are hemispherical, it is characterised in that: the cavity is provided with diaphragm, and the diaphragm will be described
Cavity is divided into two chambers, and the diaphragm has the micropore penetrated through for liquid, and the transfusion catheter is connected to the port
One end of body and one of chamber.
2. two-chamber venous transfusion according to claim 1 port, it is characterised in that: the diaphragm is pellosil, the silica gel
Film with a thickness of 1.0-1.5mm.
3. two-chamber venous transfusion according to claim 1 port, it is characterised in that: the outer surface of the port body it is corresponding it is described every
Identification rings are provided at film.
4. two-chamber venous transfusion according to claim 3 port, it is characterised in that: the identification rings are becket, the mark
Know outwardly protrusion of the ring from port body.
5. two-chamber venous transfusion according to claim 1 port, it is characterised in that: the transfusion catheter and port body difference
Connecting pin is provided with the connector of tubulose, connector has helicitic texture or buckle structure, the transfusion catheter and the port
Body is detachably connected by the connector.
6. two-chamber venous transfusion according to claim 1 port, it is characterised in that: the transfusion catheter is medical silica-gel material
Transfusion catheter or polythene material transfusion catheter, the outer diameter of transfusion catheter is 4-7F, length 130-160mm, the port body
Internal diameter is 7-9mm, length 35-40mm, wall thickness 2-3mm, and the length for the chamber being connected to transfusion catheter is 25-30mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820895290.4U CN209713828U (en) | 2018-06-08 | 2018-06-08 | Two-chamber venous transfusion port |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201820895290.4U CN209713828U (en) | 2018-06-08 | 2018-06-08 | Two-chamber venous transfusion port |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN209713828U true CN209713828U (en) | 2019-12-03 |
Family
ID=68658066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201820895290.4U Active CN209713828U (en) | 2018-06-08 | 2018-06-08 | Two-chamber venous transfusion port |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN209713828U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785791A (en) * | 2018-06-08 | 2018-11-13 | 谢博宇 | The application method of two-chamber venous transfusion port and its venous transfusion, drug storage sustained release |
-
2018
- 2018-06-08 CN CN201820895290.4U patent/CN209713828U/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108785791A (en) * | 2018-06-08 | 2018-11-13 | 谢博宇 | The application method of two-chamber venous transfusion port and its venous transfusion, drug storage sustained release |
| CN108785791B (en) * | 2018-06-08 | 2020-12-18 | 谢博宇 | Double-lumen venous transfusion port capable of preventing thrombosis and preventing secondary infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104399145B (en) | A kind of double lumen tube self-sealing venous detaining needle | |
| GB2459101A (en) | Subcutaneous port and catheter | |
| CN205031651U (en) | Malleation lasts administering means and needle, central venous catheter are kept somewhere to vein | |
| WO2012064881A2 (en) | Hemodialysis access system | |
| JP2010507455A (en) | Body fluid overflow prevention catheter | |
| CN206007700U (en) | A kind of full-implantation type venous transfusion port | |
| US20090306606A1 (en) | Catheter hub assembly with vascular access port | |
| CN105013045A (en) | Positive-pressure continuous liquid supply device, venous indwelling needle and central venous catheter | |
| WO2015010222A1 (en) | Self-sealing anti-thrombotic venous indwelling needle and use method thereof | |
| CN107412912A (en) | It is a kind of to continue micro- transfusion vein indwelling needle | |
| CN108785791A (en) | The application method of two-chamber venous transfusion port and its venous transfusion, drug storage sustained release | |
| CN201200674Y (en) | Infusion device | |
| EP0929340A1 (en) | Vein catheter for coaxial blood stream and use of a split needle for its introduction in a vein | |
| CN209713828U (en) | Two-chamber venous transfusion port | |
| CN109107020A (en) | Subcutaneous embedded type puncture device for hemodialysis arteriovenous puncture | |
| CN213131264U (en) | Anti-clogging implantable drug delivery device | |
| CN104399146B (en) | A kind of coaxial trocar sheath self-sealing venous detaining needle | |
| CN203370152U (en) | Self-sealing thrombus prevention venous indwelling needle | |
| CN218793363U (en) | IV port | |
| JP2602109B2 (en) | Drug injection system | |
| CN220110199U (en) | Switchable venous indwelling needle | |
| JP2003531690A (en) | Cannula assembly | |
| CN215460909U (en) | Implantable drug delivery device | |
| CN215653096U (en) | Non-destructive needle | |
| CN216877426U (en) | Thrombosis-proof central venous catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |